TRIO - Translational Research in Oncology Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • TRIO - Translational Research in Oncology's estimated annual revenue is currently $27.9M per year.(i)
  • TRIO - Translational Research in Oncology's estimated revenue per employee is $112,200

Employee Data

  • TRIO - Translational Research in Oncology has 249 Employees.(i)
  • TRIO - Translational Research in Oncology grew their employee count by 1% last year.

TRIO - Translational Research in Oncology's People

NameTitleEmail/Phone
1
VP, Medical AffairsReveal Email/Phone
2
VP Information ServicesReveal Email/Phone
3
Director, FinanceReveal Email/Phone
4
Associate DirectorReveal Email/Phone
5
Director, Business Development and Clinical Start-up Unit (CSU)Reveal Email/Phone
6
Human Resources ManagerReveal Email/Phone
7
Senior Start-Up ManagerReveal Email/Phone
8
Senior Clinical Trial ManagerReveal Email/Phone
9
Manager Data ManagementReveal Email/Phone
10
Senior Clinical Trial ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4980M280824%N/A$9.3B
#2
$336.9M1676N/AN/AN/A
#3
$6.8M34-11%N/AN/A
Add Company

What Is TRIO - Translational Research in Oncology?

TRIO is a not-for-profit academic clinical research organization that is dedicated to advancing translational cancer research by bringing forward innovative and targeted therapeutic concepts into the clinical trial setting. TRIO offices are based in Canada, France and Uruguay. With an international network of 2000 investigators and 450 cancer centers in over 45 different countries, TRIO has conducted a number of new and innovative global studies evaluating systemic therapy for cancer.

keywords:N/A

N/A

Total Funding

249

Number of Employees

$27.9M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TRIO - Translational Research in Oncology News

2022-04-06 - TRIO Obtains the Great Place to Work® Certification in Uruguay

MONTEVIDEO, Uruguay, April 11, 2022 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global oncology clinical research...

2022-03-30 - Trio Named To Canada's Top Employer List For Second ...

EDMONTON, April 06, 2022 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), a global academic clinical research organization,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$50.3M2549%N/A
#2
$82M2576%N/A
#3
$35M2574%N/A
#4
$76.6M2587%N/A
#5
$93.4M26313%N/A